|
Total (n = 140)
|
Male (n = 73)
|
Female (n = 67)
|
P-value
|
---|
Age (years)
|
62.06 ± 11.17
|
63.20 ± 9.56
|
60.87 ± 12.66
|
n.s.
|
Disease duration (years)
|
9.90 ± 8.02
|
9.37 ± 6.90
|
10.48 ± 9.10
|
n.s.
|
Living together with
| | | | |
(includes multiple answers)
| | | | |
Spouse
|
113 (80.7%)
|
69 (94.5%)
|
44 (65.7%)
| |
Sibling (s)
|
1 (0.7%)
|
0 (0%)
|
1 (1.5%)
| |
Children
|
82 (58.6%)
|
34 (46.6%)
|
48 (71.6%)
| |
Father/Mother
|
20 (14.3%)
|
9 (1.2%)
|
11 (1.6%)
| |
Other
|
2 (1.4%)
|
1 (0.1%)
|
1 (0.1%)
| |
Treatment method (s)
| | | | |
(includes multiple answers)
| | | | |
Diet
|
77 (55.0%)
|
42 (57.5%)
|
35 (52.2%)
| |
Exercise
|
55 (39.3%)
|
35 (47.9%)
|
20 (29.9%)
| |
Oral hypoglycemic agents
|
93 (66.4%)
|
53 (72.6%)
|
40 (59.7%)
| |
Insulin
|
28 (20.0%)
|
8 (11.0%)
|
20 (29.9%)
| |
Oral + Insulin
|
7 (0.5%)
|
2 (0.3%)
|
4 (0.6%)
| |
HbA1c (%, NGSP*)
|
7.27 ± 1.23
|
7.09 ± 1.06
|
7.47 ± 1.39
|
n.s.
|
- Data are expressed as mean ± SD.
- Statistical analysis was performed by unpaired t-test or Mann–Whitney U test.
- n.s.: not significant.
- *: NGSP, National Glycohmoglobin Standardization Program.